(Q33793209)

29 July 2017

title

Identification of four potential epigenetic modulators from the NCI structural diversity library using a cell-based assay (English)

1 reference

29 July 2017

Anne M Best

1

1 reference

29 July 2017

Jianjun Chang

2

1 reference

29 July 2017

Angie B Dull

3

1 reference

29 July 2017

John A Beutler

4

1 reference

29 July 2017

Elisabeth D Martinez

5

1 reference

29 July 2017

publication date

22 December 2010

1 reference

Journal of Biomedicine and Biotechnology

29 July 2017

published in

1 reference

29 July 2017

volume

2011

1 reference

29 July 2017

page(s)

868095

1 reference

Creative Commons Attribution 3.0 Unported

29 July 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

A quantitative high-throughput screen identifies potential epigenetic modulators of gene expression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Histone deacetylases: target enzymes for cancer therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

The epigenomics of cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Development of assays for nuclear receptor modulators using fluorescently tagged proteins

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

High-content fluorescence-based screening for epigenetic modulators

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis"

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Chromatin modifier enzymes, the histone code and cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Identification of a small molecule inhibitor of Sir2p

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3014726

28 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

Histone deacetylase inhibitors in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

Mechanism of secalonic acid D-induced inhibition of transcription factor binding to cyclic AMP response element in the developing murine palate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

Epigenetics, DNA methylation, and chromatin modifying drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

A Continuous Protein Methyltransferase (G9a) Assay for Enzyme Activity Measurement and Inhibitor Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F868095

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234371

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2011/868095

1 reference

29 July 2017

1 reference

29 July 2017

1 reference